Dear Steve and all,
Thank you for stimulating the debate.
One rational for the term “Portosinusoidal vascular disease (PSVD)” is precisely that PSVD natural history starts -like all liver diseases- with a form without portal hypertension. A term referring to portal hypertension (e.g. idiopathic portal hypertension) does not allow to take that aspect into account (and leads us to focusing on the tip of the iceberg).
Parsing these patients by associated or underlying conditions is likely a good idea, but for the moment we lack data allowing us to identify the precise groups of patients.
At ILC2021 -organised by EASL- in June, there will be a session on PSVD, with a debate on these points. I invite all VALDIG members to join this interactive session.
- Joint Webinar: Liver Transplantation and Vascular Liver Disorders – 3th October 2023
- Minutes of VALDIG general assembly meeting June 23 2023
- Minutes of VALDIG general assembly meeting July 5 2022
- VALDIG-EASL-ERN Webinar 14th June 2022 – 17h CEST
- Webinar chaired by Andrea Mancuso on portal vein thrombosis in cirrhosis
No comments to show.